Literature DB >> 16807657

Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation.

Stephen O Brennan1, Michael W Mosesson, Robin Lowen, Christopher Frantz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16807657     DOI： 10.1160/TH05-11-0749

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  3 in total

1.  Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)).

Authors:  Asier Jayo; Erin Arnold; Consuelo González-Manchón; David Green; Susan T Lord
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

2.  Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutation.

Authors:  Woosuk S Hur; David S Paul; Emma G Bouck; Oscar A Negrón; Jean-Marie Mwiza; Lauren G Poole; Holly M Cline-Fedewa; Emily G Clark; Lih Jiin Juang; Jerry Leung; Christian J Kastrup; Tatiana P Ugarova; Alisa S Wolberg; James P Luyendyk; Wolfgang Bergmeier; Matthew J Flick
Journal:  Blood       Date:  2022-03-03       Impact factor: 22.113

Review 3.  Fibrinogen αC domain: Its importance in physiopathology.

Authors:  Jeannette Soria; Shahsoltan Mirshahi; Sam Qiumars Mirshahi; Remi Varin; Linda L Pritchard; Claudine Soria; Massoud Mirshahi
Journal:  Res Pract Thromb Haemost       Date:  2019-02-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.